Pre-coating with protein fractions inhibits nano-carrier aggregation in human blood plasma

No abstract is available for this paper.

• Publication year

  2016

• Venue

  RSC Advances

• Publication date

  2016-10-10

• Fields of study

  Medicine, Materials Science, Chemistry

• Identifiers
  DOI 10.1039/C6RA17028E
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Biomolecular Coronas Provide the Biological Identity of Nanomaterials

  2017cited by this paper
• Protein source and choice of anticoagulant decisively affect nanoparticle protein corona and cellular uptake.

  2016cited by this paper
• Protein adsorption is required for stealth effect of poly(ethylene glycol)- and poly(phosphoester)-coated nanocarriers.

  2016cited by this paper
• Charged surface groups of nanoparticles and the adsorbed proteins codetermine the fate of nanoparticles upon interacting with cells

  2016cited by this paper
• Surface chemistry and serum type both determine the nanoparticle-protein corona.

  2015cited by this paper
• The "sweet" side of the protein corona: effects of glycosylation on nanoparticle-cell interactions.

  2015cited by this paper
• In Vivo Biomolecule Corona around Blood-Circulating, Clinically Used and Antibody-Targeted Lipid Bilayer Nanoscale Vesicles.

  2015cited by this paper
• Protein corona of nanoparticles: distinct proteins regulate the cellular uptake.

  2015cited by this paper
• Towards understanding of nanoparticle–protein corona

  2015cited by this paper
• Complementary analysis of the hard and soft protein corona: sample preparation critically effects corona composition.

  2015cited by this paper
• Crucial role of the protein corona for the specific targeting of nanoparticles.

  2015cited by this paper
• Mapping protein binding sites on the biomolecular corona of nanoparticles.

  2015cited by this paper
• Magnetic nanoparticles to recover cellular organelles and study the time resolved nanoparticle-cell interactome throughout uptake.

  2014cited by this paper
• Personalized protein coronas: a "key" factor at the nanobiointerface.

  2014cited by this paper
• Aggregation Behavior of Polystyrene-Nanoparticles in Human Blood Serum and its Impact on the in vivo Distribution in Mice

  2014cited by this paper
• Protein Corona Composition of Superparamagnetic Iron Oxide Nanoparticles with Various Physico-Chemical Properties and Coatings

  2014cited by this paper
• Size and charge of nanoparticles following incubation with human plasma of healthy and pancreatic cancer patients.

  2014cited by this paper
• Mass spectrometry and imaging analysis of nanoparticle-containing vesicles provide a mechanistic insight into cellular trafficking.

  2014cited by this paper
• Effect of the protein corona on nanoparticles for modulating cytotoxicity and immunotoxicity

  2014cited by this paper
• Polymeric nanoparticles of different sizes overcome the cell membrane barrier.

  2013cited by this paper
• Time evolution of nanoparticle-protein corona in human plasma: relevance for targeted drug delivery.

  2013cited by this paper
• Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology.

  2013cited by this paper
• Medicinal chemistry meets proteomics: fractionation of the human plasma proteome.

  2013cited by this paper
• Transferrin-functionalized nanoparticles lose their targeting capabilities when a biomolecule corona adsorbs on the surface.

  2013cited by this paper
• Designing the nanoparticle-biomolecule interface for "targeting and therapeutic delivery".

  2012cited by this paper
• Transferrin Coated Nanoparticles: Study of the Bionano Interface in Human Plasma

  2012cited by this paper
• How shape influences uptake: interactions of anisotropic polymer nanoparticles and human mesenchymal stem cells.

  2012cited by this paper
• Suppressing unspecific cell uptake for targeted delivery using hydroxyethyl starch nanocapsules.

  2012cited by this paper
• Understanding and controlling the interaction of nanomaterials with proteins in a physiological environment.

  2012cited by this paper
• Reversible versus irreversible binding of transferrin to polystyrene nanoparticles: soft and hard corona.

  2012cited by this paper
• Toward a molecular understanding of nanoparticle–protein interactions

  2012cited by this paper
• Administration, distribution, metabolism and elimination of polymer therapeutics.

  2012cited by this paper
• Interactions between solubilized polymer molecules and blood components.

  2012cited by this paper
• Surface roughness and charge influence the uptake of nanoparticles: fluorescently labeled pickering-type versus surfactant-stabilized nanoparticles.

  2012cited by this paper
• Nanoparticle-induced unfolding of fibrinogen promotes Mac-1 receptor activation and inflammation.

  2011cited by this paper
• Differential uptake of functionalized polystyrene nanoparticles by human macrophages and a monocytic cell line.

  2011cited by this paper
• Protein-nanoparticle interactions: opportunities and challenges.

  2011cited by this paper
• Criteria impacting the cellular uptake of nanoparticles: a study emphasizing polymer type and surfactant effects.

  2011cited by this paper
• The evolution of the protein corona around nanoparticles: a test study.

  2011cited by this paper
• Evaluation of nanoparticle aggregation in human blood serum.

  2010cited by this paper
• Endocytosis of nanomedicines.

  2010cited by this paper
• What the cell "sees" in bionanoscience.

  2010cited by this paper
• The softer and more hydrophobic the better: influence of the side chain of polymethacrylate nanoparticles for cellular uptake.

  2010cited by this paper
• Antibody purification: affinity chromatography - protein A and protein G Sepharose.

  2010cited by this paper
• The influence of protein adsorption on nanoparticle association with cultured endothelial cells.

  2009cited by this paper
• A quantitative fluorescence study of protein monolayer formation on colloidal nanoparticles.

  2009cited by this paper
• Nanoparticle interaction with plasma proteins as it relates to particle biodistribution, biocompatibility and therapeutic efficacy.

  2009cited by this paper
• Nanoparticle size and surface properties determine the protein corona with possible implications for biological impacts

  2008cited by this paper
• Adsorbed proteins influence the biological activity and molecular targeting of nanomaterials.

  2007cited by this paper
• Understanding the nanoparticle–protein corona using methods to quantify exchange rates and affinities of proteins for nanoparticles

  2007cited by this paper
• Protein A chromatography for antibody purification.

  2007cited by this paper
• Fetuin mediates hepatic uptake of negatively charged nanoparticles via scavenger receptor.

  2007cited by this paper
• Absolute Quantification of Proteins by LCMSE

  2006cited by this paper
• Adsorption-induced conformational changes of proteins onto ceramic particles: differential scanning calorimetry and FTIR analysis.

  2006cited by this paper
• Influence of the surface properties on nanoparticle-mediated transport of drugs to the brain.

  2004cited by this paper
• Silica nanoparticle size influences the structure and enzymatic activity of adsorbed lysozyme.

  2004cited by this paper
• Functional groups on polystyrene model nanoparticles: influence on protein adsorption.

  2003cited by this paper
• Surface-modified biodegradable albumin nano- and microspheres. II: effect of surface charges on in vitro phagocytosis and biodistribution in rats.

  1998cited by this paper
• Serum opsonins and liposomes: their interaction and opsonophagocytosis.

  1992cited by this paper
• Particle size, surface hydrophobicity and interaction with serum of parenteral fat emulsions and model drug carriers as parameters related to RES uptake.

  1992cited by this paper
• Distribution and elimination of coated polymethyl [2-14C]methacrylate nanoparticles after intravenous injection in rats.

  1984cited by this paper
• Studies on the mechanism of binding of serum albumins to immobilized cibacron blue F3G A.

  1980cited by this paper
• pH gradient elution of human IgG1, IgG2 and IgG4 from protein A-sepharose.

  1979cited by this paper
• Selective removal of albumin from plasma by affinity chromatography.

  1973cited by this paper

• Protein Adsorption on Nano- and Microparticles: Dependence on Morphological and Physicochemical Properties of Particles and Effect on Particle–Cell Interactions

  2025cites this paper
• Pre-programming the protein corona: From avoidance to endogenous targeting.

  2025cites this paper
• Overcoming colloidal nanoparticle aggregation in biological milieu for cancer therapeutic delivery: Perspectives of materials and particle design.

  2024cites this paper
• Analysis of Erythrocyte Sedimentation Rate Order in Epithelial Ovarian Cancer

  2023cites this paper
• Artificial engineering of the protein corona at bio-nano interfaces for improved cancer-targeted nanotherapy.

  2022cites this paper
• Physicochemical properties and antibacterial application of silver nanoparticles stabilized by whey protein isolate

  2022cites this paper
• Reduced cytotoxicity of nanomaterials driven by nano-bio interactions: Case study of single protein coronas enveloping polymersomes.

  2022cites this paper
• Pre-coating of protein modulate patterns of corona formation, physiological stability and cytotoxicity of silver nanoparticles.

  2021cites this paper
• Reaction Order Parameters of Erythrocyte Sedimentation Rate, Neutrophil-to-Lymphocyte Ratio, and Platelet-to-Lymphocyte Ratio as Markers for Colorectal Carcinoma After Chemotherapy

  2021cites this paper
• Supramolecular engineering of hydrogels for drug delivery.

  2021cites this paper
• Synthesis of Fe@C nanoparticles containing sulfo groups on their surfaces and study of their aggregation behavior in aqueous media

  2021cites this paper
• Recent Developments in the Design of Non-Biofouling Coatings for Nanoparticles and Surfaces

  2020cites this paper
• Nanovaccine impact on dendritic cells: transcriptome analysis enables new insights into antigen and adjuvant effects.

  2020cites this paper
• Utilizing corona on functionalized selenium nanoparticles for loading and release of doxorubicin payload

  2019cites this paper
• Possibilities and Limitations of Different Separation Techniques for the Analysis of the Protein Corona.

  2019cites this paper
• Prevention of Dominant IgG Adsorption on Nanocarriers in IgG‐Enriched Blood Plasma by Clusterin Precoating

  2019cites this paper
• Nanocarriers and Immune Cells

  2019cites this paper
• Möglichkeiten und Limitierungen verschiedener Trenntechniken zur Analyse der Proteinkorona

  2019cites this paper
• Highly Loaded Semipermeable Nanocapsules for Magnetic Resonance Imaging.

  2018cites this paper
• Quantification of fluorescent dyes in organ tissue samples via HPLC analysis.

  2018cites this paper
• Engineering Proteins at Interfaces: From Complementary Characterization to Material Surfaces with Designed Functions

  2018cites this paper
• From organelle over cell to tissue: Development of fluorescence-based methods to monitor the fate of model transporting structures

  2018cites this paper
• Engineering von Proteinen an Oberflächen: Von komplementärer Charakterisierung zu Materialoberflächen mit maßgeschneiderten Funktionen

  2018cites this paper
• Protein denaturation caused by heat inactivation detrimentally affects biomolecular corona formation and cellular uptake.

  2018cites this paper
• Understanding the elusive protein corona of thermoresponsive nanogels.

  2018cites this paper
• The Transferability from Animal Models to Humans: Challenges Regarding Aggregation and Protein Corona Formation of Nanoparticles.

  2018influential citation
• Exploiting the biomolecular corona: pre-coating of nanoparticles enables controlled cellular interactions.

  2018cites this paper
• Interactions of organic nanoparticles with proteins in physiological conditions.

  2017cites this paper
• Protein Corona: Impact of Lymph Versus Blood in a Complex In Vitro Environment.

  2017cites this paper